Science Corporation

Science Corporation

Private
Alameda, CaliforniaHealthcare & Life Scienceshttps://science.xyz/

Last Round

Series C

3/5/2026

Est. Valuation

$1.5B

Total Funding Raised

$494M

Momentum Score

50 /100

Company Overview

Science Corporation is a clinical-stage medical technology company founded in 2021 by Max Hodak, former president of Neuralink. The company focuses on developing advanced technologies in neural engineering and brain-computer interfaces (BCI) to treat debilitating conditions and restore lost functions such as vision and mobility. One of its main projects is the Science Eye, a visual prosthesis designed to treat blindness from diseases like retinitis pigmentosa and age-related macular degeneration. In addition to its internal product development, the company operates Science Foundry, a micro-electro-mechanical systems (MEMS) fabrication facility that provides services to both internal teams and external customers to accelerate innovation in the field. The company is headquartered in Alameda, California, with additional offices in North Carolina and France.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Semiconductors, Sensors, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription, Government Contracts

AI Layer

Application

Keywords

brain-computer interfaceBCIvision restorationretinal implantbionic eyeScience Eyeneural engineeringvisual prosthesisneurotechnologymacular degeneration treatmentMEMS fabricationBCI ecosystemmicrofabrication servicesphotovoltaic implant

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Science Corporation Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Science Corporation Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series C3/5/2026
Convertible Debt4/15/2025
Series B11/22/2022
Series A7/21/2021

Key People

Founding team and executive leadership

Max Hodak

Board Member, Founder and CEO

Founding Team

Tricia Gugler

Chief Financial Officer

Executive Team

Science Corporation Investors

Notable investors and investment history

InvestorRounds
Khosla VenturesConvertible Debt, Series C
Y CombinatorSeries C
In-Q-TelSeries C
Quiet CapitalSeries C
Lightspeed Venture PartnersSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 13, 2026

    Partnered with Card79 on an unspecified project.

  • Apr 13, 2026

    Received the iF Design Award 2026 for Product Design.

Science Corporation Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Science Corporation Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Science Corporation's valuation, stock price, and market status.

Firmographic Details

HeadquartersAlameda, California
Employee Range284
Year Founded2021
Last Funding3/5/2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.